Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
用户P-mPQbgVJoNg
1个月前
72
10
已完结
1. 系统已在2026-04-09 11:54:02对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1470-2045(25)00189-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204525001895
其他信息:
出版社: Elsevier BV
作者: Karim Fizazi; Michael J Morris; Neal D Shore; Kim N Chi; Michael Crosby; Johann S de Bono; Ken Herrmann; Guilhem Roubaud; James Nagarajah; Mark Fleming; Brian Lewis; Luke Nordquist; Natalie Carnahan; Samson Ghebremariam; Marianna Hertelendi; Daniel Castellano; Oliver Sartor
